News

Filter

Current filters:

Sanofi

226 to 235 of 414 results

Growing US uptake of Genzyme's Aubagio at three months post-launch

07-03-2013

Some 34% of surveyed US neurologists have prescribed French drug major Sanofi (Euronext: SAN) subsidiary…

AubagioBiotechnologyGenzymeMarkets & MarketingNeurologicalNorth AmericaPharmaceuticalSanofi

AAD conference briefs: Celgene's apremilast; and Sanofi's dupilumab

04-03-2013

The European subsidiary of US biotech firm Celgene Corp (Nasdaq: CELG) presented the results from ESTEEM…

apremilastBiotechnologyCelgeneDermatologicalsdupilumabPharmaceuticalRegeneronResearchSanofi

US FDA accepts Sanofi's NDA for diabetes drug lixisenatide

19-02-2013

The US Food and Drug Administration has accepted for review French drug major Sanofi's (Euronext: SAN)…

DiabeteslixisenatideNorth AmericaPharmaceuticalRegulationSanofiZealand Pharma

Genzyme's eliglustat meets endpoints in Ph III studies for Gaucher disease

18-02-2013

US biotech firm Genzyme, a subsidiary if French drug major Sanofi (Euronext: SAN) has released positive…

BiotechnologyeliglustatGenzymePharmaceuticalRare diseasesResearchSanofi

226 to 235 of 414 results

Back to top